Locations:
Search IconSearch
April 1, 2026/Giving

Transplant Leads to Research Funding

Suzanne and R. Madison Murphy

Suzanne and R. Madison Murphy

“Being able to breathe again was like nothing I've ever experienced. It was miraculous,” says R. Madison Murphy. “I took a deep breath and went, whoa, this is amazing.”

Madison was recalling his experience of recovering from a lung transplant at Cleveland Clinic in May 2025, just a year after his diagnosis of pulmonary fibrosis. “I hadn't forgotten what it felt like to take a deep breath. I just couldn't do it.”

Madison and his wife, Suzanne, still live in El Dorado, Arkansas, where they first met in seventh grade science class. They’ve been married for 46 years. Madison rose to success in his family’s oil and timber business, whose interests now include a family-run California winery. He and Suzanne are generous supporters of higher education and healthcare in south Arkansas and an arts district they helped create in El Dorado.

Trouble Ahead

Madison had his first lung surgery at age 62 in 2019 for a collapsed lung. Although his history of smoking cigars, pipes and cigarettes was long in the past, doctors warned that his lungs were not in good shape. Then, in early 2024, he had a triple-bypass. During cardiac rehab he still was experiencing shortness of breath. This led to a visit with a pulmonologist in Little Rock who advised him to go someplace that does a lot of lung transplants, because that's what he was going to need.

The Murphys were already donors to Cleveland Clinic because of their excellent treatment at Cole Eye Institute. They quickly learned that Cleveland Clinic's Lung Transplant Program is a leader in lung transplants, both for patient volumes and successful outcomes. More than 2,500 transplants have been performed since the program's inception in 1990, with long term survival rates above the national average.

By April 2024, Madison was at Cleveland Clinic for testing and scans, including X-rays, laboratory tests and breathing tests, and while he was not shocked by the diagnosis of pulmonary fibrosis – his mother passed away from the disease in 1996, long before any real treatment existed – Madison and Suzanne were alarmed by how quickly his symptoms progressed. He was placed on the transplant list on February 1, 2025, and the waiting began.

“It was totally surreal because I'd had heart surgery and other cardiovascular issues but I never thought I was going to die from those things,” Madison says. “I realize I may have come pretty close, but to be told you probably do not have a year to live and you need to do all this testing to ascertain if you can be a candidate for a transplant? That's sobering.”

A Type of Lung Disease

Pulmonary fibrosis is a scarring and thickening in the lungs that makes it hard to breathe deeply. It’s a type of interstitial lung disease, which affects the tissue between the air sacs in the lungs (alveoli).

Hard, stiff lung tissues don’t expand as well as they should. Patients with pulmonary fibrosis may get short of breath during daily tasks that never seemed tiring before. Pulmonary fibrosis is permanent and usually gets progressively worse over time. There is no cure for pulmonary fibrosis.

The Ultimate Gift

Madison and Suzanne just happened to be in Cleveland when they got the call.

“It's absolutely profound. And this is where I'll get emotional … Someone else's tragedy and grief provided me and my family with relief, hope and an extraordinary gift. Then the surgeons and the care team do everything to make it happen. It's overwhelming. It's highly emotional, frankly. And it should be. If it isn't, then I think something's probably wrong,” Madison says quietly.

“He wrote a beautiful letter to express his gratitude to the donor’s family,” Suzanne added. “I cried when I read it.”

Over the months of testing and waiting, Madison and Suzanne had formed a close relationship with Marie Budev, DO, MPH, Medical Director of the Lung and Heart-Lung Transplant Program at Cleveland Clinic. “She's such a compassionate person,” says Suzanne.

“This disease isn’t understood very well,” notes Madison. “They can do the transplant, which is a miracle in and of itself, but what are causal factors? What other things does it affect? Apparently a lot.”

A Connection Between Pulmonary Fibrosis and Telomeres?

After learning about Dr. Budev’s study of telomeres and their impact on lung transplantation success and outcomes, Madison and Suzanne were curious, because Madison was found to have shortened telomeres. A telomere is a region of repetitive DNA sequences at the end of a chromosome. Telomeres protect the ends of chromosomes from becoming frayed or tangled. Each time a cell divides, the telomeres become slightly shorter. Eventually, they become so short that the cell can no longer divide successfully, and the cell dies.

Researchers have found that patients with idiopathic pulmonary fibrosis who have shortened telomeres tend to have worse outcomes after transplantation.

Today, blood samples collected from patients at Cleveland Clinic with idiopathic pulmonary fibrosis are shared with the Johns Hopkins Diagnostic Lab, a Nobel Prize winning laboratory, to verify if they have shortened telomeres. Dr. Budev and her team recently began collecting data to be entered into databases for study and have already yielded an incredible success rate of identifying new patients with shortened telomeres.

A Catalyst for Research

Grateful for the exemplary care and intrigued by Dr. Budev’s telomere research, Madison and Suzanne made a gift of $2 million to fund the first-of-its-kind Short Telomere Clinic and help determine how telomere length impacts transplant patients clinically.

Because shortened telomeres affect many aspects of the patient’s health, this dedicated clinic will ensure that patients are seen by a multidisciplinary team to best handle their care, improve outcomes and help inform treatment options. “Currently around 10% of our transplant patients have shortened telomeres, which impacts the care we provide,” says Dr. Budev. “Expanding our research will provide significant insights into this population.”

“We came here because reputationally and statistically, Cleveland Clinic is the best in the world,” says Madison emphatically. “And they're not just reputationally and statistically and clinically the best in the world – they’re the best in the world, period. They have done this for so long and so well that they understand how you feel and what you need to know to be able to deal with it. And the doctors are incredibly smart, very humble and empathetic. They're completely focused on you – the patient – trying to save your life.”

Latest from the Newsroom

Survey results for Cleveland Clinic’s 11th annual MENtion It® campaign.

Cleveland Clinic: Despite Men Not Trusting What They See Online, Some Are Letting Social Media Drive Their Behaviors

Medical illustration of Lipoprotein(a)

First in Human Long-Acting Gene Silencing Therapy Significantly Lowers Heart Disease Risk Marker with One Injection

Medical illustration of CRISPR technology

Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely and Continuously Lower Cholesterol and Triglycerides After One Year

Discussion at the AI Summit for Healthcare Professionals

Cleveland Clinic AI Summit Highlights Growing Role of Artificial Intelligence in Healthcare

A Cleveland Clinic team performs the first robotic nipple-sparing mastectomy procedure in Ohio

Cleveland Clinic First in Ohio to Perform Robotic Nipple-Sparing Mastectomy

Dr. Brenessa Lindeman

Brenessa Lindeman, M.D., Appointed Executive Dean of Cleveland Clinic Lerner College of Medicine

Logos for Cleveland Clinic and West Side Market

Cleveland Clinic Pledges $1 Million to Support Teaching Kitchen at West Side Market

Exterior photo of Cleveland Clinic's Main Campus

Cleveland Clinic One of the Nation’s Best Hospitals